Coparion
Investor profile
Venture capital
Also recorded as: coparion
Deals
40
distinct rounds
Companies
34
backed
Active span
2017–2024
8 yrs
Total round €
€784M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- High-Tech Gründerfonds (HTGF)4
- HV Capital4
- Senovo4
- Keen Venture Partners3
- Venture Stars3
- VR Ventures3
- 83North2
- Balderton Capital2
- Bayern Kapital2
- BioMedPartners2
- Deutsche Bank2
- DN Capital2
- Earlybird Venture Capital2
- EQT Ventures2
- FundPlus2
- Lios Ventures2
- Prime Ventures2
- Seventure Partners2
- Unternehmertum Venture Capital Partners2
- UVC Partners2
- Vito Ventures2
- Abacon Capital1
- Abiomed1
- Aiven1
- AllIron1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Holidu | Germany | 2 | €112M |
| Grover | Germany | 1 | €101M |
| Lendis | Germany | 1 | €80M |
| Cardior Pharmaceuticals | Germany | 1 | €64M |
| Tubulis Technologies | Germany | 1 | €60M |
| CatalYm | Germany | 1 | €50M |
| Abalos Therapeutics | Germany | 1 | €43M |
| Protembis | Germany | 2 | €39M |
| Plan A | Germany | 2 | €34M |
| Finoa | Germany | 2 | €34M |
| Lanes & Planes | Germany | 1 | €33M |
| Clark | Germany | 1 | €25M |
| Wirelane | Germany | 1 | €18M |
| Homelike | Germany | 1 | €12M |
| Shyftplan | Germany | 2 | €10M |
| 3YourMind | Germany | 1 | €10M |
| Nuri | Germany | 1 | €9.0M |
| TwentyBN | Germany | 1 | €8.6M |
| Finanzguru | Germany | 1 | €8.0M |
| Lofelt | Germany | 1 | €5.8M |
| Vimcar | Germany | 1 | €5.0M |
| Bitwala | Netherlands | 1 | €4.0M |
| ContractHero | Germany | 2 | €3.6M |
| emlen | Germany | 1 | €3.6M |
| Oniq | Germany | 1 | €3.5M |
| Autovio | Germany | 1 | €3.0M |
| micropsi industries | Germany | 1 | €2.0M |
| Veertly | Switzerland | 1 | €1.9M |
| koppla | Germany | 1 | €1.6M |
| ParcelLab | Germany | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Grover | Other | €101M | 2022-04 |
| Lendis | Series A | €80M | 2022-01 |
| Holidu | Other | €75M | 2022-10 |
| Cardior Pharmaceuticals | Series B | €64M | 2021-08 |
| Tubulis Technologies | Series B | €60M | 2022-05 |
| CatalYm | Series C | €50M | 2022-11 |
| Abalos Therapeutics | Series A | €43M | 2021-10 |
| Holidu | Series D+ | €37M | 2021-05 |
| Lanes & Planes | Other | €33M | 2023-10 |
| Protembis | Series B | €30M | 2024-03 |